MUC15 inhibits hepatoma cell self-renewal, malignant proliferation, tumorigenicity, and chemoresistance by interacting with c-Met and subsequently inactivating the PI3K/AKT/SOX2 signaling pathway. This evidence concerns the gene MUC15 and hepatocellular carcinoma.